Inclusion criteria in BE studies [Design Issues]

posted by BEQool  – 2023-05-05 12:42 (714 d 01:17 ago) – Posting: # 23543
Views: 3,705
(edited on 2023-05-05 12:52)

❝ Just wish to mention that Gender is a between-subject factor (at least for most practical purposes ex-Thailand), so there is no particular gain in including Gender as a factor when you have Subject in the model unless there is a specific regulatory requirement.


Hello,
maybe a stupid question but is Gender*Treatment also a between-subject factor (like Sequence and Gender here)?
In the article Evaluation of sex-by-formulation interaction in bioequivalence studies of efavirenz tablets by González-Rojano et al. it doesnt say anything about which factor they used (within- or between-subject) to test Gender*Treatment interaction.

Additionally, how do you know which factor is a within-subject and which is a between-subject? If anyone has an explanation in simple words :-)

Complete thread:

UA Flag
Activity
 Admin contact
23,424 posts in 4,927 threads, 1,711 registered users;
21 visitors (0 registered, 21 guests [including 8 identified bots]).
Forum time: 13:59 CEST (Europe/Vienna)

Do not worry about your difficulties in mathematics.
I can assure you mine are still greater.    Albert Einstein

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5